23638295|t|Protective Effect of Safranal, a Constituent of Crocus sativus, on Quinolinic Acid-induced Oxidative Damage in Rat Hippocampus.
23638295|a|OBJECTIVE(S): Quinolinic acid (QA)-mediated excitotoxicity has been widely used as a model for studying neurodegenerative disorders. Recent studies suggested that saffron (Crocus sativus) or its active metabolite, i.e. safranal, exerts pharmacological actions on central nervous system including anxiolytic, anticonvulsant, and neuroprotective properties. The present study aimed to investigate the effect safranal pretreatment on QA-induced oxidative damage in rat hippocampus. MATERIALS AND METHODS: Under anesthesia, a guide cannula was stereotaxically inserted into left ventral hippocampus of rats. The rats were then given either saline or safranal (72.75, 145.5, and 291 mg/kg, IP) 30 min before administration of QA (300 nmol, intrahippocampal injection). The markers of oxidative stress including thiobarbituric acid reactive substances (TBARS, as an index of lipid preoxidation), total sulfhydryl groups, antioxidant capacity of hippocampus (using FRAP assay), and oxidative DNA damage (%tail DNA, using comet assay) were measured in hippocampus. RESULTS: The QA induced a significant increase in TBARS levels and %tail DNA and remarkable decrease in antioxidant power (FRAP value) and total sulfhydryl content of hippocampus, in comparison with control animals. Systemic administration of safranal (291 mg/kg, IP), effectively and dose-dependently decreased the QA-induced lipid peroxidation (P<0.001) and oxidative DNA damage (P<0.001). Safranal also prevented the decrease of hippocampal thiol redox and antioxidant status (P<0.001) produced by QA. CONCLUSION: Safranal have protective effects on different markers of oxidative damage in hippocampal tissue following QA administration. Our findings might raise a possibility of potential therapeutic application of safranal for preventing and treating neurodegenerative disorders such as Alzheimer's disease.
23638295	21	29	Safranal	Chemical	MESH:C087963
23638295	45	62	of Crocus sativus	Chemical	-
23638295	67	82	Quinolinic Acid	Chemical	MESH:D017378
23638295	91	100	Oxidative	Disease	MESH:D028361
23638295	101	107	Damage	Disease	MESH:D020263
23638295	111	114	Rat	Species	10116
23638295	142	157	Quinolinic acid	Chemical	MESH:D017378
23638295	159	161	QA	Chemical	MESH:D017378
23638295	172	186	excitotoxicity	Disease	
23638295	232	259	neurodegenerative disorders	Disease	MESH:D019636
23638295	300	314	Crocus sativus	Species	82528
23638295	347	355	safranal	Chemical	MESH:C087963
23638295	534	542	safranal	Chemical	MESH:C087963
23638295	559	561	QA	Chemical	MESH:D017378
23638295	570	579	oxidative	Disease	MESH:D028361
23638295	580	586	damage	Disease	MESH:D020263
23638295	590	593	rat	Species	10116
23638295	726	730	rats	Species	10116
23638295	736	740	rats	Species	10116
23638295	774	782	safranal	Chemical	MESH:C087963
23638295	849	851	QA	Chemical	MESH:D017378
23638295	907	916	oxidative	Disease	MESH:D028361
23638295	934	973	thiobarbituric acid reactive substances	Chemical	MESH:D017392
23638295	975	980	TBARS	Chemical	MESH:D017392
23638295	997	1002	lipid	Chemical	MESH:D008055
23638295	1024	1041	sulfhydryl groups	Chemical	MESH:D013438
23638295	1103	1112	oxidative	Disease	MESH:D028361
23638295	1113	1123	DNA damage	Disease	MESH:D004266
23638295	1198	1200	QA	Chemical	MESH:D017378
23638295	1235	1240	TBARS	Chemical	MESH:D017392
23638295	1330	1340	sulfhydryl	Chemical	MESH:D013438
23638295	1428	1436	safranal	Chemical	MESH:C087963
23638295	1501	1503	QA	Chemical	MESH:D017378
23638295	1512	1517	lipid	Chemical	MESH:D008055
23638295	1545	1554	oxidative	Disease	MESH:D028361
23638295	1555	1565	DNA damage	Disease	MESH:D004266
23638295	1577	1585	Safranal	Chemical	MESH:C087963
23638295	1629	1634	thiol	Chemical	MESH:D013438
23638295	1686	1688	QA	Chemical	MESH:D017378
23638295	1702	1710	Safranal	Chemical	MESH:C087963
23638295	1759	1768	oxidative	Disease	MESH:D028361
23638295	1769	1775	damage	Disease	MESH:D020263
23638295	1808	1810	QA	Chemical	MESH:D017378
23638295	1906	1914	safranal	Chemical	MESH:C087963
23638295	1943	1970	neurodegenerative disorders	Disease	MESH:D019636
23638295	1979	1998	Alzheimer's disease	Disease	MESH:D000544
23638295	Negative_Correlation	MESH:C087963	MESH:D017378
23638295	Positive_Correlation	MESH:D017378	MESH:D020263
23638295	Negative_Correlation	MESH:C087963	MESH:D028361
23638295	Negative_Correlation	MESH:C087963	MESH:D000544
23638295	Positive_Correlation	MESH:D017378	MESH:D017392
23638295	Positive_Correlation	MESH:D017378	MESH:D019636
23638295	Negative_Correlation	MESH:C087963	MESH:D004266
23638295	Positive_Correlation	MESH:D017378	MESH:D004266
23638295	Negative_Correlation	MESH:C087963	MESH:D008055
23638295	Positive_Correlation	MESH:C087963	MESH:D013438
23638295	Negative_Correlation	MESH:C087963	MESH:D020263
23638295	Association	MESH:D008055	MESH:D017378
23638295	Association	MESH:D017392	MESH:D028361
23638295	Positive_Correlation	MESH:D017378	MESH:D028361
23638295	Association	MESH:D008055	MESH:D028361
23638295	Negative_Correlation	MESH:C087963	MESH:D019636
23638295	Negative_Correlation	MESH:D013438	MESH:D017378

